Public research preview
Daniel Goldman, Representative disclosure: Truist Financial Corporation Common Stock (TFC)
Disclosed a buy transaction in Truist Financial Corporation Common Stock (TFC). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 19 May 2023, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 39 days
Timeline
Transaction date
10 Apr 2023
Public disclosure
19 May 2023
Now
Tracked today
Filing delay: 39 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 10 Jun 2026
Stock path
TFC from pre-transaction context through latest close.
Bought
10 Apr 2023 · 27,898 USD · Not public yet
System decision
Would not buy — The strategy's filters reject this signal. Failed filters: Filed within 30 days.
- Not public yet
- Would not buy
- Observed transaction close
- 27,898
- Observed disclosure close
- 25,454
- Observed latest close
- 48,83
- Pre-disclosure move
- -8.8%
- Post-disclosure move
- +91.8%
- Market-adjusted move
- +91.8%
- Pre-disclosure peak run-up
- +4.9%
- Retrace from peak
- -13.0%
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $15,001 - $50,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 19 May 2023, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%